The pathophysiological role of estrogen receptor variants in human breast cancer

Journal of Steroid Biochemistry and Molecular Biology

Volumn 65, Issue 1-6, 1998, Pages 175-180

  Murphy, Leigh C ^a   Dotzlaw, Helmut ^a   Leygue, Etienne ^a   Coutts, Amanda ^a   Watson, Peter ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA; RECEPTOR SUBTYPE;

BINDING AFFINITY; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CONFERENCE PAPER; ESTROGEN THERAPY; FEMALE; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; VARIATION (GENETICS);

EID: 0032052806     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(98)00012-0     Document Type: Conference Paper

References (39)

1. Tsai M. J., O'Malley B. W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63:1994;451-486.
2. Katzenellenbogen B. S. Estrogen receptors: Bioactivities and interactions with cell signaling pathways. Biol. Reprod. 54:1996;287-293.
3. George, F. W. and Wilson, J. D. Sex determination and differentiation. In The Physiology of Reproduction, ed. E. Knobil and J. D. Neill. Raven Press, New York, 1988, pp. 3.
4. Spicer, D. and Malcolm, C. Epidemiology of breast cancer. In Treatment of the postmenopausal woman: basic and clinical aspects, ed. R. Lobo. Raven Press, New York, 1994, pp. 315-324.
5. Turner R., Riggs B., Spelsberg T. Skeletal effects of estrogens. Endocr. Rev. 15:1994;275-300.
6. Barrett-Conner E., Bush T. Estrogens and coronary heart disease in women. J. Am. Med. Ass. 265:1991;1861-1867.
7. Murphy L. Mechanisms associated with the progression of breast cancer from hormone dependence to independence. Pezcoller Found. J. 2:1995;6-16.
8. Katzenellenbogen B. S., Korach K. S. A new actor in the estrogen receptor drama-enter ER-beta. Endocrinology. 138:1997;861-862. editorial.
9. Murphy, L., Leygue, E., Dotzlaw, H., Douglas, D., Coutts, A. and Watson, P. Oestrogen receptor variants and mutations in human breast cancer. Ann. Med., 29 (1997) 221-234.
10. Fuqua S. A., Wolf D. M. Molecular aspects of estrogen receptor variants in breast cancer. Breast Cancer Res. Treat. 35:1995;233-241.
11. Dotzlaw H., Alkhalaf M., Murphy L. C. Characterization of estrogen receptor variant mRNAs from human breast cancers. Mol. Endocrinol. 6:1992;773-785.
12. Fuqua S. A., Allred D. C., Auchus R. J. Expression of estrogen receptor variants. J. Cell. Biochem. Suppl. 17G:1993;194-197.
13. Leygue E., Huang A., Murphy L., Watson P. Prevalence of estrogen receptor variant messenger RNAs in human breast cancer. Cancer Res. 56:1996;4324-4327.
14. Fasco M. Quantitation of estrogen receptor mRNA and its alternatively spliced mRNAs in breast tumor cells and tissues. Anal. Biochem. 245:1997;167-178.
15. Fuqua S. A., Fitzgerald S. D., Allred D. C., Elledge R. M., Nawaz Z., McDonnell D. P., O'Malley B. W., Greene G. L., McGuire W. L. Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res. 52:1992;483-486.
16. Pfeffer U., Fecarotta E., Arena G., Forlani A., Vidali G. Alternative splicing of the estrogen receptor primary transcript normally occurs in estrogen receptor positive tissues and cell lines. J. Steroid Biochem. Mol. Biol. 56:1996;99-105.
17. Daffada A. A., Johnston S. R., Smith I. E., Detre S., King N., Dowsett M. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer. Cancer Res. 55:1995;288-293.
18. Leygue E. R., Watson P. H., Murphy L. C. Estrogen receptor variants in normal human mammary tissue. J. Natl. Cancer Inst. 88:1996;284-290.
19. Murphy L. C., Dotzlaw H. Variant estrogen receptor mRNA species detected in human breast cancer biopsy samples. Mol. Endocrinol. 3:1989;687-693.
20. Murphy L. C., Hilsenbeck S. G., Dotzlaw H., Fuqua S. A. W. Relationship of clone 4 estrogen receptor variant messenger RNA expression to some known prognostic variables in human breast cancer. Clin. Cancer Res. 1:1995;155-159.
21. Inoue S., Hoshino S., Miyoshi H., Akishita M., Hosoi T., Orimo H., Ouchi Y. Identification of a novel isoform of estrogen receptor, a potential inhibitor of estrogen action, in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 219:1996;766-772.
22. Tzukerman M., Esty A., Santiso-Mere D., Danielian P., Parker M., Stein R., Pike J., McDonnell D. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 8:1994;21-30.
23. Berry M., Metzger D., Chambon P. Role of the two activating domains of the oestrogen receptor in the cell type and promoter context dependent agonistic activity of the antioestrogen 4 hydroxytamoxifen. EMBO J. 9:1990;2811-2818.
24. Pfeffer U., Fecarotta E., Vidali G. Coexpression of multiple estrogen receptor variant messenger RNAs in normal and neoplastic breast tissues and in MCF-7 cells. Cancer Res. 55:1995;2158-2165.
25. Leygue E., Dotzlaw H., Watson P. H., Murphy L. C. Identification of novel exon-deleted progesterone receptor variant mRNAs in human breast tissue. Biochem. Biophys. Res. Commun. 228:1996;63-68.
26. Hollenberg S., Weinberger C., Ong E., Cerelli G., Oro A., Lebo R., Thompson E., Rosenfeld M., Evans R. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature. 318:1985;635-641.
27. Baker A., McDonnell D., Hughes M., Crisp T., Mangelsdorf D., Haussler M., Pike J., Shine J., O'Malley B. Cloning and expression of full length cDNA encoding human vitamin D receptor. Proc. Natl. Acad. Sci. USA. 85:1988;3294-3298.
28. Leygue E., Murphy L., Kuttenn F., Watson P. Triple primer polymerase chain reaction. A new way to quantify truncated mRNA expression. Am. J. Pathol. 148:1996;1097-1103.
29. Castles C. G., Fuqua S. A., Klotz D. M., Hill S. M. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line. Cancer Res. 53:1993;5934-5939.
30. Desai A., Luqmani Y., Coope R., Dagg B., Gomm J., Pace P., Rees C., Thirunavukkarasu V., Shousha S., Groome N., Coombes R., Ali S. Presence of exon 5 deleted oestrogen receptor in human breast cancer: Functional analysis and clinical significance. Br. J. Cancer. 75:1997;1173-1184.
31. Park W., Choi J., Hwang E., Lee J. Identification of a variant estrogen receptor lacking exon 4 and its coexpression with wild type estrogen receptor in ovarian carcinomas. Clin. Cancer Res. 2:1996;2029-2035.
32. Huang A., Pettigrew N., Watson P. Immunohistochemical assay for oestrogen receptors in paraffin wax sections of breast carcinoma using a new monoclonal antibody. J. Pathol. 180:1996;223-227.
33. Huang, A., Leygue, E., Snell, L., Murphy, L., and Watson, P. Expression of estrogen receptor variants mRNAs and determination of estrogen status in human breast cancer. American Journal of Pathology, 150 (1997) 1827-1833.
34. Fuqua S. A., Fitzgerald S. D., Chamness G. C., Tandon A. K., McDonnell D. P., Nawaz Z., O'Malley B. W., McGuire W. L. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res. 51:1991;105-109.
35. Wang Y., Miksicek R. J. Identification of a dominant negative form of the human estrogen receptor. Mol. Endocrinol. 5:1991;1707-1715.
36. Coutts, A., Leygue, E., and Murphy, L. Mechanisms of hormone independence in human breast cancer cells. Abstract 1988. In 88th Annual Meeting of the American Association for Cancer Research. San Diego, CA, 1997, pp. 296.
37. Erenburg, I., Mira-y-Lopez, R., Ossowski, L., and Schachter, B. Effects of estrogen receptor splice isoform on mammary cell function. Abstract P2-794. In The 10th International Congress of Endocrinology. San Francisco, 1996.
38. Rea D., Parker M. G. Effects of an exon 5 variant of the estrogen receptor in MCF-7 breast cancer cells. Cancer Res. 56:1996;1556-1563.
39. Green S., Walter P., Kumar V., Krust A., Bornert J., Argos P., Chambon P. Human estrogen receptor cDNA: sequence, expression, and homology to v-erb-A. Nature. 320:1986;134-139.